Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
The gut microbiome and its resistome as predictors of clinical infections and phenotypic antibiotic resistance in hematopoietic stem cell transplant recipients.
Clusters of post-acute COVID-19 symptoms: a latent class analysis across 9 databases and 7 countries.
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.
Transdermal delivery of enfuvirtide using dissolving microneedles integrated with novel insertion and removal indicator.
2025 update of the drug resistance mutations in HIV-1.
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1.
Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species.
Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study.
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.